Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
ANALYSIS OF THE EFFECT OF CHEMOTHERAPY IN OVARIAN CANCER TREATMENT USING DATA MINING Kezban Alpan Middlesex University PLCO Nov 1, 2022 PLCO-1089
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco LSS Oct 27, 2022 LSS-3
Assessing the effect of different kinds of explanations on how much people trust a cancer diagnosis Ben Armstrong Massachusetts Institute of Technology PLCO Oct 27, 2022 PLCO-1080
Development of CAD for lung nodule screening Naïm Jalal GE HEALTHCARE NLST Oct 27, 2022 NLST-977
Alcohol Intake Across the Life Course and Risk of Ovarian Cancer in Postmenopausal Women Alexandra Schmidt University of North Dakota PLCO Oct 19, 2022 PLCO-1078
Synthetic generation and tagging of CXR and pathology images Jonathan Pearson NHS Commissioning Board (NHS England) PLCO Oct 18, 2022 PLCOI-1077
Utilization of machine learning to create a predictive model for ovarian cancer based on pelvic ultrasound, CA-125, and clinical characteristics Graham Chapman Case Western Reserve University PLCO Oct 18, 2022 PLCO-1074
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) Mary Playdon University of Utah PLCO Oct 18, 2022 PLCO-1067
Impact of Data Driven Decision Making in Healthcare Analytic May Myat University of Technology, Yatanarpon Cyber City(UTYCC), Pyin Oo Lwin, Myanmar PLCO Oct 18, 2022 PLCO-1064
Mathematical modelling of prostate cancer data Taylor deVet McMaster University PLCO Oct 18, 2022 PLCO-1073
Time Lag to Benefit: A Systematic Review and Meta-Analysis of Lung Cancer Screening Trials Alison Rustagi University of California, San Francisco NLST Oct 18, 2022 NLST-972
Machine Learning Analysis for Lung Cancer Progression Anderson Nnewihe Johnson & Johnson Enterprise Innovation, Inc. NLST Oct 18, 2022 NLST-973
Looking for the retrospective link between cigarette habits in men and prostate cancer Tamara yaghi American international School of riyadh PLCO Oct 11, 2022 PLCO-1071
PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL Matejka Rebolj Queen Mary University of London PLCO Oct 11, 2022 PLCO-1066
Comparative analysis of the cost-effectiveness and implementation of lung cancer screening with LDCT in the US and EU Tanya Rajabi Semmelweis University NLST Oct 11, 2022 NLST-968
Lung cancer risk assessment Adam Vasserstrom Nucleix NLST Oct 11, 2022 NLST-965
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers Sigrid Carlsson Memorial Sloan Kettering Cancer Center PLCO Oct 6, 2022 2021-1016
Dissecting the risk of MGUS/MM in high-risk participants in the PLCO study Irene Ghobrial Dana-Farber Cancer Institute PLCO Oct 6, 2022 2021-1015
Homologous recombination repair capacity and breast cancer risk: a nested case control study Hua Zhao Virginia Commonwealth University PLCO Oct 6, 2022 2021-1005
Diurnal pattern of physical activity and adherence to physical activity Tongyu Ma Franklin Pierce University IDATA Oct 3, 2022 IDATA-57